Skip to main content

and
Your search also matched 6 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Include preview-only content
  1. Article

    Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

    The anti-tumour effects associated with oncolytic virus therapy are mediated significantly through immune-mediated mechanisms, which depend both on the type of virus and the route of delivery. Here, we show th...

    E Ilett, T Kottke, J Thompson, K Rajani, S Zaidi, L Evgin, M Coffey in Gene Therapy (2017)

  2. Article

    Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma

    A fully intact immune system would be expected to hinder the efficacy of oncolytic virotherapy by inhibiting viral replication. Simultaneously, however, it may also enhance antitumor therapy through initiation...

    F Galivo, R M Diaz, P Wongthida, J Thompson, T Kottke, G Barber, A Melcher in Gene Therapy (2010)